David F. Chang, MD, explained how offering complementary refractive IOLs reduces patient anxiety and indecision.

Jacque Duncan, MD, reviews phase 3 DRAGON data on oral tinlarebant for Stargardt disease and its mechanism-related visual ...

Vaidehi Dedania, MD, shared what the first whole eye transplant revealed about reperfusion, retinal cells, and sight. Dedania ...

The course is designed for comprehensive and pediatric ophthalmologists and optometrists, who often see patients with new ...

When people ask how I define a successful premium IOL outcome, they usually expect a number. The honest answer is that a ...

Elizabeth A. Davis MD, FACS | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology ...